Ignyta to Present at the Jefferies 2017 London Healthcare Conference
November 09 2017 - 4:00PM
Business Wire
Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company
focused on precision medicine in oncology, announced today that
Jacob Chacko, M.D., its Chief Financial Officer, will make a
presentation at the Jefferies 2017 London Healthcare Conference on
November 16, 2017, at 1:20 p.m. local time (5:20 a.m. Pacific time)
in London, UK.
A webcast of the presentation will be available during the
presentation in the Investors section of the company's website at
https://www.ignyta.com/investors/, and will be archived and
available at that site for 14 days.
About Ignyta, Inc.
Blazing a New Future for Patients with
Cancer™
At Ignyta, we work tirelessly on behalf of patients with
cancer to offer potentially life-saving, precisely targeted
therapeutics (Rx) guided by diagnostic (Dx) tests. Our integrated
Rx/Dx strategy allows us to enter uncharted territory, illuminating
the molecular and immunological drivers of cancer and quickly
advancing treatments to address them. This approach embraces even
those patients with rare cancers, who have the highest unmet need
and who may otherwise not have access to effective treatment
options. With our pipeline of potentially first-in-class or
best-in-class precision medicines, we are pursuing the ultimate
goal of not just shrinking tumors, but eradicating cancer relapse
and recurrence in precisely defined patient populations.
For more information, please visit: www.ignyta.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171109005330/en/
Ignyta, Inc.Jacob Chacko, M.D.CFO858-255-5959jc@ignyta.com
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Prometheus Biosciences (NASDAQ:RXDX)
Historical Stock Chart
From Apr 2023 to Apr 2024